Year: 2021

news_6

Dr. Reddy’s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its...

news_6

Philippine Airlines Inc. (PAL) Reaches Agreement with Key Stakeholders to Successfully Navigate the COVID-19 Pandemic and Position the Company for Long-Term Growth and Profitability

Flights to continue uninterrupted and all valid tickets, vouchers, refund applications and Mabuhay Miles to be honored Agreements with majority...

news_6

Metals Acquisition Corp. Announces Partial Exercise and Closing of Underwriters’ Option to Purchase Additional Units in Connection With Its Initial Public Offering

FORT WORTH, Texas--(BUSINESS WIRE)--Metals Acquisition Corp. (the “Company”) today announced that the underwriters of its previously announced initial public offering...